Immunogen reported $867K in Interest Expense on Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Amgen AMGN:US USD 415M 47M
Bristol Myers Squibb BMY:US USD 294M 5M
Halozyme Therapeutics HALO:US USD 7.51M 4.41M
Immunogen IMGN:US USD 867K 211K
Intrexon XON:US USD 2.04M 27K
Karyopharm Therapeutics KPTI:US USD 6.11M 199K
Nektar Therapeutics NKTR:US USD 6.95M 275K
Novartis NVS:US USD 219M 4M
Pfizer PFE:US USD 313M 2M
Regeneron Pharmaceuticals REGN:US USD 17.4M 2.1M
Roche Holding ROG:VX 256M 90M